Pioglitazone in patients with insulin resistance after ischemic stroke or transient ischemic attack: A comment on the IRIS trial.
Second Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippocration Hospital, Thessaloniki, Greece.
Niki
N
Katsiki
Department of Clinical Biochemistry (Vascular Disease Prevention Clinics), Royal Free Hospital campus, University College London Medical School, University College London (UCL), London NW3 2QG, UK. Electronic address: mikhailidis@aol.com.
Dimitri P
DP
Mikhailidis
D002545:Brain Ischemia; D006801:Humans; D007333:Insulin Resistance; D002546:Ischemic Attack, Transient; D000077205:Pioglitazone; D020521:Stroke
D000077205:Pioglitazone